113 related articles for article (PubMed ID: 11956594)
21. Degradation of gonadotropin-releasing hormones in the gilthead seabream, Sparus aurata. I. Cleavage of native salmon GnRH and mammalian LHRH in the pituitary.
Goren A; Zohar Y; Fridkin M; Elhanati E; Koch Y
Gen Comp Endocrinol; 1990 Aug; 79(2):291-305. PubMed ID: 2202610
[TBL] [Abstract][Full Text] [Related]
22. Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alpha.
Wu HM; Cheng JC; Wang HS; Huang HY; MacCalman CD; Leung PC
Cancer Res; 2009 May; 69(10):4202-8. PubMed ID: 19366794
[TBL] [Abstract][Full Text] [Related]
23. Biological characterization of a novel, orally active small molecule gonadotropin-releasing hormone (GnRH) antagonist using castrated and intact rats.
Anderes KL; Luthin DR; Castillo R; Kraynov EA; Castro M; Nared-Hood K; Gregory ML; Pathak VP; Christie LC; Paderes G; Vazir H; Ye Q; Anderson MB; May JM
J Pharmacol Exp Ther; 2003 May; 305(2):688-95. PubMed ID: 12606616
[TBL] [Abstract][Full Text] [Related]
24. Gonadotropin-releasing hormone agonists reduce the migratory and the invasive behavior of androgen-independent prostate cancer cells by interfering with the activity of IGF-I.
Montagnani Marelli M; Moretti RM; Mai S; Procacci P; Limonta P
Int J Oncol; 2007 Jan; 30(1):261-71. PubMed ID: 17143537
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of gonadotropin-releasing hormone III analogs. Structure-antitumor activity relationships.
Mezö I; Lovas S; Pályi I; Vincze B; Kálnay A; Turi G; Vadász Z; Seprödi J; Idei M; Tóth G; Gulyás E; Otvös F; Mák M; Horváth JE; Teplán I; Murphy RF
J Med Chem; 1997 Oct; 40(21):3353-8. PubMed ID: 9341910
[TBL] [Abstract][Full Text] [Related]
26. Alterations in intracellular messengers mobilized by gonadotropin-releasing hormone in an experimental ovarian tumor.
Chamson-Reig A; Pignataro OP; Libertun C; Lux-Lantos VA
Endocrinology; 1999 Aug; 140(8):3573-80. PubMed ID: 10433213
[TBL] [Abstract][Full Text] [Related]
27. Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system.
Günthert AR; Gründker C; Bongertz T; Schlott T; Nagy A; Schally AV; Emons G
Am J Obstet Gynecol; 2004 Oct; 191(4):1164-72. PubMed ID: 15507937
[TBL] [Abstract][Full Text] [Related]
28. Enzymatic stability, solution structure, and antiproliferative effect on prostate cancer cells of leuprolide and new gonadotropin-releasing hormone peptide analogs.
Pappa EV; Zompra AA; Spyranti Z; Diamantopoulou Z; Pairas G; Lamari FN; Katsoris P; Spyroulias GA; Cordopatis P
Biopolymers; 2011; 96(3):260-72. PubMed ID: 20632397
[TBL] [Abstract][Full Text] [Related]
29. Gonadotropin releasing hormone analogs induce apoptosis by extrinsic pathway involving p53 phosphorylation in primary cell cultures of human prostatic adenocarcinomas.
Clementi M; Sánchez C; Benitez DA; Contreras HR; Huidobro C; Cabezas J; Acevedo C; Castellón EA
Prostate; 2009 Jul; 69(10):1025-33. PubMed ID: 19301301
[TBL] [Abstract][Full Text] [Related]
30. Evidence for tight coupling of gonadotropin-releasing hormone receptor to stimulated Fas ligand expression in reproductive tract tumors: possible mechanism for hormonal control of apoptotic cell death.
Imai A; Takagi A; Horibe S; Takagi H; Tamaya T
J Clin Endocrinol Metab; 1998 Feb; 83(2):427-31. PubMed ID: 9467552
[TBL] [Abstract][Full Text] [Related]
31. Advanced indications for gonadotropin-releasing hormone (GnRH) analogues in gynecological oncology (review).
Sugiyama M; Imai A; Takahashi S; Hirano S; Furui T; Tamaya T
Int J Oncol; 2003 Aug; 23(2):445-52. PubMed ID: 12851694
[TBL] [Abstract][Full Text] [Related]
32. An agonist-induced switch in G protein coupling of the gonadotropin-releasing hormone receptor regulates pulsatile neuropeptide secretion.
Krsmanovic LZ; Mores N; Navarro CE; Arora KK; Catt KJ
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2969-74. PubMed ID: 12591945
[TBL] [Abstract][Full Text] [Related]
33. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
Schubert A; Schulz H; Emons G; Gründker C
Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
[TBL] [Abstract][Full Text] [Related]
34. Cell growth effects of leuprolide on cultured endometrioma cells.
Levine D; Kaufman L; Cuenca VG; Badawy SZ
J Reprod Med; 2007 Jul; 52(7):581-4. PubMed ID: 17847754
[TBL] [Abstract][Full Text] [Related]
35. Evidence for a two-step mechanism of gonadotropin-releasing hormone metabolism by prolyl endopeptidase and metalloendopeptidase EC 3.4.24.15 in ovine hypothalamic extracts.
Lew RA; Tetaz TJ; Glucksman MJ; Roberts JL; Smith AI
J Biol Chem; 1994 Apr; 269(17):12626-32. PubMed ID: 8175672
[TBL] [Abstract][Full Text] [Related]
36. The involvement of phosphatidylinositol 3-kinase in gonadotropin-releasing hormone-induced gonadotropin alpha- and FSHbeta-subunit genes expression in clonal gonadotroph LbetaT2 cells.
Mutiara S; Kanasaki H; Harada T; Oride A; Miyazaki K
Mol Cell Endocrinol; 2008 Feb; 283(1-2):1-11. PubMed ID: 18206295
[TBL] [Abstract][Full Text] [Related]
37. Gonadotropin-releasing hormone induces apoptosis of prostate cancer cells: role of c-Jun NH2-terminal kinase, protein kinase B, and extracellular signal-regulated kinase pathways.
Kraus S; Levy G; Hanoch T; Naor Z; Seger R
Cancer Res; 2004 Aug; 64(16):5736-44. PubMed ID: 15313914
[TBL] [Abstract][Full Text] [Related]
38. Endocrine signaling in ovarian surface epithelium and cancer.
Leung PC; Choi JH
Hum Reprod Update; 2007; 13(2):143-62. PubMed ID: 17071638
[TBL] [Abstract][Full Text] [Related]
39. Regulation of ovarian angiogenesis and apoptosis by GnRH-I analogs.
Parborell F; Irusta G; Rodríguez Celín A; Tesone M
Mol Reprod Dev; 2008 Apr; 75(4):623-31. PubMed ID: 17874466
[TBL] [Abstract][Full Text] [Related]
40. Evidence that prostate gonadotropin-releasing hormone receptors mediate an anti-tumourigenic response to analogue therapy in hormone refractory prostate cancer.
Gnanapragasam VJ; Darby S; Khan MM; Lock WG; Robson CN; Leung HY
J Pathol; 2005 Jun; 206(2):205-13. PubMed ID: 15818594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
